Cargando…

Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes

AIM: To assess the factors associated with antihyperglycaemic medication initiation in UK patients with newly diagnosed type 2 diabetes. METHODS: In a retrospective cohort study, patients with newly diagnosed type 2 diabetes were identified during the index period of 2003-2005. Eligible patients wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinclair, Alan J, Alexander, Charles M, Davies, Michael J, Zhao, Changgeng, Mavros, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353844/ https://www.ncbi.nlm.nih.gov/pubmed/22397700 http://dx.doi.org/10.1186/1472-6823-12-1

Ejemplares similares

Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program
por: Matthews, David R., et al.
Publicado: (2020)

Safety and efficacy of antihyperglycaemic agents in diabetic kidney disease
por: Niezen, Sebastian, et al.
Publicado: (2019)

The Change in HbA1c Associated with Initial Adherence and Subsequent Change in Adherence among Diabetes Patients Newly Initiating Metformin Therapy
por: Nichols, Gregory A., et al.
Publicado: (2016)

Study of antihyperglycaemic activity of medicinal plant extracts in alloxan induced diabetic rats
por: Attanayake, Anoja P., et al.
Publicado: (2013)

Prandial–basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes
por: Jain, S M, et al.
Publicado: (2010)

Risk of any hypoglycaemia with newer antihyperglycaemic agents in patients with type 2 diabetes: A systematic review and meta‐analysis
por: Kamalinia, Sanaz, et al.
Publicado: (2019)

Antihyperglycaemic Effect of Tetracarpidium Conophorum Nuts in Alloxan Induced Diabetic Female Albino Rats
por: Onwuli, Donatus Onukwufor, et al.
Publicado: (2014)

Antihyperglycaemic and tissue-repair effects of Myrmeleon formicarius extract in streptozotocin-induced diabetic mice
por: Prihatin, Jekti, et al.
Publicado: (2019)

Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study
por: Zhang, Qiaoyi, et al.
Publicado: (2011)

Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis
por: Gillett, M, et al.
Publicado: (2010)

Teneligliptin As an Initial Therapy for Newly Diagnosed, Drug Naive Subjects With Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2014)

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
por: Ma, Jing, et al.
Publicado: (2016)

Initial Medication in Patients of Newly Diagnosed Parkinson’s Disease in Taiwan
por: Guo, Yi-Jen, et al.
Publicado: (2014)

Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity
por: Zhang, X., et al.
Publicado: (2014)

Paederia foetida Linn. leaf extract: an antihyperlipidemic, antihyperglycaemic and antioxidant activity
por: Kumar, Vikas, et al.
Publicado: (2014)

Aqueous extract of Tamarindus indica fruit pulp exhibits antihyperglycaemic activity
por: Krishna, Rajesh Nivesh, et al.
Publicado: (2020)

Depression in newly diagnosed type 2 diabetes
por: Yu, Ruan, et al.
Publicado: (2010)

Antihyperglycaemic activity of 2,4:3,5-dibenzylidene-D-xylose-diethyl dithioacetal in diabetic mice
por: Gruzman, Arie, et al.
Publicado: (2012)

Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1
por: Sedman, Tuuli, et al.
Publicado: (2016)

Antiobesity and antihyperglycaemic effects of Adiantum capillus-veneris extracts: in vitro and in vivo evaluations
por: Kasabri, Violet, et al.
Publicado: (2016)

Influence of traditional processing and genotypes on the antioxidant and antihyperglycaemic activities of yellow-fleshed cassava
por: Kareem, Babajide, et al.
Publicado: (2022)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Trends in Pain Medication Initiation Among Patients With Newly Diagnosed Diabetic Peripheral Neuropathy, 2014-2018
por: Fan, Jungwei, et al.
Publicado: (2021)

Investigation of Antihyperglycaemic Activity of Banana (Musa sp. Var. Nanjangud rasa bale) Flower in Normal and Diabetic Rats
por: Ramu, Ramith, et al.
Publicado: (2017)

Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial
por: Arakaki, R F, et al.
Publicado: (2014)

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
por: Khera, Rohan, et al.
Publicado: (2023)

Newly Diagnosed Type 1 Diabetes in an Elderly Patient
por: Cosme, Inês, et al.
Publicado: (2023)

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2022)

The Application of Ultrasonic Waves and Microwaves to Improve Antihyperglycaemic and Antimicrobial Activities of Marrubium vulgare Extracts
por: Gavarić, Aleksandra, et al.
Publicado: (2022)

A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience
por: Zhang, Xiaomei, et al.
Publicado: (2020)

Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China
por: He, Xiaoning, et al.
Publicado: (2020)

Effects of sitagliptin as initial therapy in newly diagnosed elderly type 2 diabetics: A randomized controlled study
por: Xiao, Xiaoyan, et al.
Publicado: (2016)

Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Marrett, Elizabeth, et al.
Publicado: (2012)

Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey
por: Ng, Sze May, et al.
Publicado: (2020)

Multicentre service evaluation of presentation of newly diagnosed cancers and type 1 diabetes in children in the UK during the COVID-19 pandemic
por: Williams, Gemma, et al.
Publicado: (2021)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Raised liver enzymes in newly diagnosed type 2 diabetes
por: Joob, Beuy, et al.
Publicado: (2013)

Association of newly diagnosed type 1 diabetes and autoimmune pancreatitis
por: Ennazk, Laila, et al.
Publicado: (2016)

Clinical phenotyping of newly diagnosed type 2 diabetes in Yemen
por: Gunaid, Abdallah Ahmed, et al.
Publicado: (2018)

Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
por: Unnikrishnan, A. G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sabu2qjnbu890lehlemvue5o2o